Category: Public Policy

Investments, costs, regulations, laws, courts and prisons– what helps? What’s useless or worse- harmful? What’s the cost to the taxpayer? And the economy? And the families? And, oh, yes… the people suffering from addictive disease?

Public Policy

Cannabis and Crime

by C. Scott McMillin | Aug 9, 2021 | Public Policy, Resources | 0 |

Incarceration can be costly, disruptive to families, and appears to do little to deter future drug use. And though people do change while incarcerated, it isn’t always for the better.

Going Forward

by C. Scott McMillin | Aug 2, 2021 | Public Policy | 0 |
Cleaning Up the Mess

by C. Scott McMillin | Jul 22, 2021 | Public Policy | 0 |
A Different Kind of Hangover

by C. Scott McMillin | Jul 12, 2021 | Public Policy | 0 |
An Update on Needle Exchange

by C. Scott McMillin | Jul 8, 2021 | Public Policy, Resources | 0 |
Canadian Cannabusiness

by C. Scott McMillin | May 10, 2021 | Addictive Substances, Public Policy | 0 |

Opioids in the News! …Again

by C. Scott McMillin | May 3, 2021 | Public Policy | 0 |

…politics is built on compromise, and addiction is a disease that, like coronavirus, makes its own rules and insists we observe them.

Cannabis and The Age of First Use

by C. Scott McMillin | Apr 29, 2021 | Public Policy | 0 |

…how would a whole industry based in recreational pot reduce access for underage kids?

It’s About Equality

by C. Scott McMillin | Apr 15, 2021 | Addictive Substances, Public Policy | 0 |

They wanted the problem off the street and out of their neighborhoods, post-haste. “If they’re locked up, they can’t buy or sell drugs,” proclaimed an angry parent

The Pot Debate, Summarized

by C. Scott McMillin | Apr 12, 2021 | Public Policy | 0 |

Apparently many in the public assume numbers don’t lie, which if you work with stats, you quickly realize is not true.

Cruel or Fair?

by C. Scott McMillin | Apr 1, 2021 | Public Policy | 0 |

But over the years, a pattern has emerged: an effort that begins as prevention or rehabilitation swings to the other side if the results don’t meet expectations, or don’t arrive quickly enough.

The FDA in Two Acts

by C. Scott McMillin | Mar 29, 2021 | Public Policy | 0 |

It’s the opposite of transparency, and greatly limits opportunities to improve the system, so as to reduce the risk of future boondoggles.

Cannabis Coalition

by C. Scott McMillin | Mar 22, 2021 | Public Policy | 0 |

Feels a bit like the city fathers of Tombstone in the midst of an outbreak of gunfighting, deciding that maybe now would be a good time to hire a couple more deputies.